| Trial ID: | L0606 |
| Source ID: | NCT00883415
|
| Associated Drug: |
Darbepoetin Alfa
|
| Title: |
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00883415/results
|
| Conditions: |
Cardiomyopathy|Chronic Kidney Disease|Anemia
|
| Interventions: |
DRUG: Darbepoetin alfa
|
| Outcome Measures: |
Primary: Change to Myocardial Glucose Uptake as Measured by Fluoro-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Scan From Pre-treatment Compared to 6 Months After Anemia Therapy Initiation., Change in myocardial glucose uptake from baseline to 6 months expressed as change in micromol/min/100 g, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore | Collaborators: Amgen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
20
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-05
|
| Completion Date: |
2012-11
|
| Results First Posted: |
2020-05-21
|
| Last Update Posted: |
2020-05-21
|
| Locations: |
Baltimore VA Medical Center, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00883415
|
